NeuroSense Therapeutics Ltd. (NRSNW) Free cash flow 2021–2025
NeuroSense Therapeutics Ltd. (NRSNW) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$7.7MFY2025 · since FY2021: -$1.6M → -$7.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.7M | +24.3% |
| FY2024 | -$10.1M | -20.9% |
| FY2023 | -$8.4M | -9.1% |
| FY2022 | -$7.7M | -394.0% |
| FY2021 | -$1.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice